EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Temporal and Spatial Metabolic Shifts Revealing the Transition from Ulcerative Colitis to Colitis‐Associated Colorectal Cancer

Ruiqi Sun, Yuanyuan Zhang, Xian Zhao, Tian Tang, Yuepeng Cao, Liu Yang, Yuan Tian, Zunjian Zhang, Pei Zhang, Fengguo Xu iD

Advanced Science · 2025-03 · 12 (11)

DOI: 10.1002/advs.202412551 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 22.01.2025. Verfasst von Ruiqi Sun und 9 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Drug Quality Control and Pharmacovigilance (Ministry of Education), State Key Laboratory of Natural Medicines, China Pharmaceutical…. Hauptthemen laut MEDLINE: Colitis, Ulcerative, Colorectal Neoplasms, Colitis-Associated Neoplasms. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundamental Research Funds for the Central Universities, Project Program of State Key Laboratory of Natural Medicines (China Pharmaceutical University), Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Patients with ulcerative colitis (UC) have a higher risk of developing colorectal cancer (CRC), however, the metabolic shifts during the UC‐to‐CRC transition remain elusive. In this study, an AOM‐DSS‐induced three‐stage colitis‐associated colorectal cancer (CAC) model is constructed and targeted metabolomics analysis and pathway enrichment are performed, uncovering the metabolic changes in this transition. Spatial metabolic trajectories in the “normal‐to‐normal adjacent tissue (NAT)‐to‐tumor” transition, and temporal metabolic trajectories in the “colitis‐to‐dysplasia‐to‐carcinoma” transition are identified through K‐means clustering of 74 spatially and 77 temporally differential metabolites, respectively. The findings reveal two distinct metabolic profile categories during the inflammation‐to‐cancer progression: those with consistent changes, either increasing (e.g., kynurenic acid, xanthurenic acid) or decreasing (e.g., long‐chain fatty acids, LCFAs), and those enriched at specific disease stages (e.g., serotonin). Further analysis of metabolites with consistent temporal trends identifies eicosapentaenoic acid (EPA) as a key metabolite, potentially exerting anti‐inflammatory and anti‐cancer effects by inhibiting insulin‐like growth factor binding protein 5 (IGFBP5). This study reveals novel metabolic mechanisms underlying the transition from UC to CAC and suggests potential targets to delay the progression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colitis, UlcerativeColorectal NeoplasmsColitis-Associated NeoplasmsAnimalsMiceDisease ProgressionMetabolomicsDisease Models, AnimalMaleHumansMice, Inbred C57BLMetabolome

Stichwörter der Autor:innen

colitis‐associated colorectal cancer (CAC)eicosapentaenoic acid (EPA)insulin‐like growth factor binding protein 5 (IGFBP5)metabolomicsulcerative colitis (UC)

Autor:innen und Institutionen

  • Key Laboratory of Drug Quality Control and Pharmacovigilance (Ministry of Education), State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, 210009, P. R. China.
  • Department of Pharmacy, Drum Tower Hospital, China Pharmaceutical University, Nanjing, 210008, P. R. China.
  • School of Pharmacy, Air Force Medical University, Xi'an, 710032, P. R. China.
  • The Affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing, 210009, P. R. China.

ORCID-Profile: Fengguo Xu

Förderung

  • Fundamental Research Funds for the Central Universities
  • Project Program of State Key Laboratory of Natural Medicines (China Pharmaceutical University)
  • Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)
  • National Natural Science Foundation of China

Zitieren

APA

Sun, R., Zhang, Y., Zhao, X., Tang, T., Cao, Y., Yang, L., Tian, Y., Zhang, Z., Zhang, P., & Xu, F. (2025). Temporal and Spatial Metabolic Shifts Revealing the Transition from Ulcerative Colitis to Colitis‐Associated Colorectal Cancer. Advanced Science, 12(11). https://doi.org/10.1002/advs.202412551

Vancouver

Sun R, Zhang Y, Zhao X, Tang T, Cao Y, Yang L, et al. Temporal and Spatial Metabolic Shifts Revealing the Transition from Ulcerative Colitis to Colitis‐Associated Colorectal Cancer. Advanced Science. 2025;12(11). doi:10.1002/advs.202412551

BibTeX
@article{Sun2025,
  author = {Sun, Ruiqi and Zhang, Yuanyuan and Zhao, Xian and Tang, Tian and Cao, Yuepeng and Yang, Liu and Tian, Yuan and Zhang, Zunjian and Zhang, Pei and Xu, Fengguo},
  title = {Temporal and Spatial Metabolic Shifts Revealing the Transition from Ulcerative Colitis to Colitis‐Associated Colorectal Cancer},
  journal = {Advanced Science},
  year = {2025},
  volume = {12},
  number = {11},
  doi = {10.1002/advs.202412551}
}
Kostenlos starten →